Local clinical development services from Phase I to IV

Providing support from its offices in Sweden, Denmark, Norway and Finland, IRW Consulting is a clinical research organisation that is passionate about becoming a preferred partner in the Nordic countries. Bringing two decades of experience, IRW works with companies of all sizes.

In a fast-moving and continuously expanding pharmaceutical industry, the need for efficient and well-documented clinical trials is evident. A clinical research organisation (CRO) is a service organisation dedicated to the pharmaceutical and biotechnology industries, offering value-added services to promote the research and development process in each field. IRW manages clinical trials from start to finish and can also act as an integrated part of a client’s research team in-house.

Clinical projects from Phase I to IV
With five offices across the Nordic region, IRW is ideally placed to provide clinical development and post-marketing support for companies of any size.
“Our local expertise and contacts mean that we can help our clients to conduct phase I to phase IV studies, including paediatric and non-interventional studies, as well as medical device investigations, according to both international and country-specific guidelines”, says Ola Jeppsson, CEO of IRW Consulting.
In addition, IRW has the capability to cover more than just the Nordic region. Through a network of partners across the rest of Europe and the USA, IRW has the ability and capacity to conduct clinical projects globally. To ensure that these hand-picked collaborators meet its own high standards of quality, IRW makes sure that they have robust quality systems in place, including well-documented standard operating procedures, solid finances and a history of good performance.

Maintaining efficient projects
As a full-service agency, IRW can manage projects from beginning to end. Clients range from start-up companies to multinational pharmaceutical corporations.
“We are able to meet the high demands of our clients and maintain projects efficiently. We have experienced staff and management. We have secured stable business during the past years, large parts of the success being due to efficient and strategic planning on our part. We are ready to take on almost any clinical project”, says Ola Jeppsson.
Lately, IRW has taken a much more prominent role in projects related to medical device investigations as well as rare diseases. Oncology is still widely represented through the project portfolio.
IRW is currently recruiting, with opportunities for clinical research associates and clinical research managers in Denmark, Finland, Norway and Sweden.


Life Science SNL 2019-3 - Affärstidningen Näringsliv

Näringsliv 2019-3

Huvudtema: Life Science
Countries and Companies Combatting Cancer

If a single disease were to be identified as” Public enemy number 1”, cancer would be a good candidate. Practically every citizen in Denmark or Sweden know someone, who have suffered ...

Back to top